Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?

Italian Heart Journal

Volumn 2, Issue 7, 2001, Pages 513-518

  Zardo, F ^a   Antonini Canterin, F ^a   Brieda, M ^a   Hrovatin, E ^a   Pavan, D ^a   Burelli, C ^a   Cervesato, E ^a   Nicolosi, G L ^a  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

Atrial fibrillation; Cardioversion; Verapamil

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; PROPAFENONE; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; DISEASE DURATION; DRUG EFFICACY; ELECTRIC SHOCK; ELECTRODE; ENERGY; FEMALE; FOLLOW UP; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART RIGHT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVENTION; PROSPECTIVE STUDY; PULMONARY ARTERY; RECURRENT DISEASE; SHORT COURSE THERAPY; SINUS RHYTHM; STATISTICAL ANALYSIS;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION, RIGHT; CALCIUM CHANNEL BLOCKERS; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; VERAPAMIL;

EID: 0034889017     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation
2. Low energy internal cardioversion of spontaneous atrial fibrillation
3. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation
4. Low-energy cardioversion of spontaneous atrial fibrillation: Immediate and long-term results
5. Acute endocavitary atrial cardioversion: What indications and limitations?
6. Internal cardioversion of chronic atrial fibrillation in patients
7. Safety of low energy transvenous atrial defibrillation. World experience
8. Low energy intracardiac cardioversion of persistent atrial fibrillation
9. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and effect of intravenous sotalol on human atrial defibrillation threshold
10. Changes in intracardiac atrial cardioversion threshold at rest and during exercise
11. Internal right atrial cardioversion of chronic atrial fibrillation: Effects of low-energy biphasic shocks
12. Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function
13. Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year
14. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation
15. Efficacia della cardioversione endocavitaria ad alta e bassa energia nella fibrillazione atriale cronica refrattaria alla cardioversione transtoracica
16. Low energy transvenous cardioversion of atrial fibrillation resistant to transthoracic shocks
17. Low energy internal cardioversion for atrial fibrillation resistant to external cardioversion
18. Antiarrhythmic drug therapy in the management of atrial fibrillation
19. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats
20. Atrial fibrillation: Current knowledge and recommendations for management
21. Electrophysiologic remodeling of the heart owing to rate
22. Electrical remodeling in atrial fibrillation: Time course and mechanisms
23. Tachycardia-induced change of atrial refractory periods in humans. Rate dependency and effects of antiarrhythmic drugs
24. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria?
25. Verapamil reduces tachycardia-induced electrical remodeling of the atria
26. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation
27. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
28. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion
29. Tachycardia-induced changes of atrial electrophysiological properties
30. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation
31. Factors influencing long-term persistence of sinus rhythm after first electrical cardioversion for atrial fibrillation
32. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling
33. Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation